Skip to content
  • Tuesday, 27 October 2026
  • 10:33 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • New Ludwig Cancer Research Study Unveils Promising Combination Therapy for Aggressive Acute Myelogenous Leukemia
Stem Cell & Regenerative Medicine

New Ludwig Cancer Research Study Unveils Promising Combination Therapy for Aggressive Acute Myelogenous Leukemia

Dwi Wanna Oct 6, 2026 0

Acute myelogenous leukemia remains one of the most formidable hematologic malignancies in modern oncology. Characterized by its rapid progression and…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Oct 2, 2026 0

Groundbreaking collaborative research from the University of Michigan and the University of California San Diego has uncovered a critical biological…

Read More
Stem Cell & Regenerative Medicine

Researchers Uncover Promising Dual-Drug Therapy to Overcome Differentiation Blockade in Aggressive Acute Myelogenous Leukemia

Dwi Wanna Sep 21, 2026 0

Acute myelogenous leukemia (AML) remains one of the most formidable hematological malignancies in modern oncology. Despite incremental advances in supportive…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Sep 16, 2026 0

Researchers at the University of Michigan and the University of California San Diego have uncovered a critical biological mechanism that…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.

Dwi Wanna Jul 20, 2026 0

A collaborative study conducted by researchers at the University of Michigan and the University of California San Diego has identified…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Jul 10, 2026 0

The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…

Read More
Environmental & Analytical Chemistry

The animal behind most aggressive wildlife encounters may surprise you

Abdurrohim Arsyad Jul 5, 2026 0

A Century of Scientific Enlightenment Established in the nascent years of modern scientific discovery, Science News emerged at a time…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.

Dwi Wanna Jun 21, 2026 0

This seminal research, conducted by a collaborative team from the University of Michigan and the University of California San Diego,…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.

Dwi Wanna Jun 3, 2026 0

A collaborative research effort between the University of Michigan and the University of California San Diego has identified a critical…

Read More
Stem Cell & Regenerative Medicine

Regional Bone Marrow Niches in the Skull Identified as Critical Defense Hubs Against Aggressive Glioblastoma Tumors

Dwi Wanna Jun 3, 2026 0

Glioblastomas represent one of the most formidable challenges in modern oncology, remaining largely incurable despite decades of intensive research. These…

Read More

Posts pagination

1 2
TWiV 1292: Clinical update with Dr. Daniel GriffinExploring the Cutting Edge: New eBook Dives into Single-Cell Spatial Omics, Cancer, Neurodevelopmental Diseases, and AI in Biomedical ResearchEClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data PlatformThe Dawn of In Vivo Cell Therapies: A New Era in Precision Medicine Unfolds Amidst Significant Investment and Innovation
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ